Europe Cell Therapy Market Forecast 2022-2030
KEY FINDINGS
The Europe cell therapy market is expected to record a CAGR of 14.63% during the forecast period, 2022-2030. Several market players in the region are collaborating to develop cell therapies. Also, many cell therapies are gaining approval in Europe. However, technical issues restrict the widespread use of cell therapies in the region.
MARKET INSIGHTS
Germany, Spain, Italy, France, the United Kingdom, Poland, Belgium, and Rest of Europe are evaluated for the Europe cell therapy market growth assessment. In Germany, there is growing adoption of advanced treatment techniques like cell therapy for treating chronic diseases like diabetes and cancer. Also, many organizations and private clinics offer cell therapy-related services and support. For instance, the German Stem Cell Network (GSCN) is actively engaged in developing stem cell research. Additionally, healthcare providers like CBC Health Munich, German International Clinic, PHI Orthopedic Physiotherapy Center, etc., offer stem cell therapy for different chronic diseases like rheumatoid arthritis, optic nerve neuritis, and retinopathy.
Furthermore, the growing partnerships among international players boost the market growth. For instance, apceth Biopharma GmbH and Hitachi Chemical Advanced Therapeutics Solutions LLC expanded their relationship with bluebird bio in November 2020 through long-term development and manufacturing service agreements for commercial and clinical supply for multiple therapies.
In Italy, government agencies are involved in developing advanced healthcare technologies. For instance, the Italian Medicines Agency (AIFA) declared in August 2019 that it would be reimbursing CAR-T cell therapy Kymriah as part of the new reimbursement approach. Such developments are expected to offer growth opportunities in these countries.
COMPETITIVE INSIGHTS
Some of the leading companies in the market are Gilead Sciences Inc, Smith & Nephew Plc, Cells for Cells SA, JCR Pharmaceuticals Co Ltd, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Increasing Cellular Therapy Clinical Trials
- 3.1.2. Growth Of Regenerative Medicine
- 3.1.3. High Prevalence Of Chronic Diseases
- 3.2. Key Restraints
- 3.2.1. Increasing Skills Gap
- 3.2.2. High Costs
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Cell Therapy Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Regulatory Framework
- 4.5. Opportunity Matrix
- 4.6. Vendor Landscape
- 5. Market By Cell Type
- 5.1. Stem Cell
- 5.1.1. Bone Marrow
- 5.1.2. Blood
- 5.1.3. Umbilical Cord-derived Stem Cell
- 5.1.4. Adipose-derived Stem Cell
- 5.1.5. Others
- 5.2. Non-stem Cell
- 6. Market By Therapy Type
- 6.1. Autologous
- 6.2. Allogeneic
- 7. Market By Therapeutic Application
- 7.1. Malignancies
- 7.2. Musculoskeletal Disorders
- 7.3. Autoimmune Disorders
- 7.4. Dermatology
- 7.5. Other Applications
- 8. Market By End-user
- 8.1. Hospitals & Clinics
- 8.2. Academic & Research Institutes
- 9. Geographical Analysis
- 9.1. Europe
- 9.1.1. Market Size & Estimates
- 9.1.2. Key Drivers
- 9.1.3. Key Challenges
- 9.1.4. Key Players
- 9.1.5. Country Analysis
- 9.1.5.1. United Kingdom
- 9.1.5.2. Germany
- 9.1.5.3. France
- 9.1.5.4. Italy
- 9.1.5.5. Spain
- 9.1.5.6. Belgium
- 9.1.5.7. Poland
- 9.1.5.8. Rest Of Europe
- 10. Competitive Landscape
- 10.1. Key Strategic Developments
- 10.1.1. Mergers & Acquisitions
- 10.1.2. Product Launches & Developments
- 10.1.3. Partnerships & Agreements
- 10.1.4. Business Expansions
- 10.2. Company Profiles
- 10.2.1. Anterogen Co Ltd
- 10.2.2. Bristol Myers Squibb Company
- 10.2.3. Cells For Cells Sa
- 10.2.4. Gilead Sciences Inc
- 10.2.5. Jcr Pharmaceuticals Co Ltd
- 10.2.6. Kolon Tissuegene Inc
- 10.2.7. Medipost Co Ltd
- 10.2.8. Mesoblast Limited
- 10.2.9. Nuvasive Inc
- 10.2.10. Smith & Nephew Plc
- 10.2.11. Stemedica Cell Technologies Inc
- 10.2.12. Vericel Corporation
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook